Showing results (21-30 of 163) with videos related to

Sort By:
Pageof 17
Plos One|February 15, 2013
IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cellsBastian Schilling, Malgorzata Harasymczuk, Patrick Schuler, et al.
Pediatric Research|July 17, 2013
Reduced frequency of CD56 dim CD16 pos natural killer cells in pediatric systemic inflammatory response syndrome/sepsis patientsE Scott Halstead, Joseph A Carcillo, Bastian Schilling, et al.
Acta Dermato-Venereologica|May 26, 2020
Indirect Comparison of Combined BRAF and MEK Inhibition in Melanoma Patients with Elevated Baseline Lactate DehydrogenaseValerie Glutsch, Teresa Amaral, Claus Garbe, et al.
Analytical Chemistry|October 4, 2022
Extending the Mass Spectrometry-Detectable Landscape of MHC Peptides by Use of Restricted Access MaterialMelissa Bernhardt, Yiliam Cruz-Garcia, Anne Rech, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2018
Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockadeLaura Milsch, Anja Gesierich, Sophia Kreft, et al.
Cancers|December 9, 2023
Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated MelanomaHeike Niessner, Anna Hüsch, Corinna Kosnopfel, et al.
Diagnostic Pathology|May 23, 2013
Lack of SF3B1 R625 mutations in cutaneous melanomaBastian Schilling, Nicola Bielefeld, Antje Sucker, et al.
European Journal of Immunology|May 16, 2012
Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patientsPatrick J Schuler, Bastian Schilling, Malgorzata Harasymczuk, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2021
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinomaValerie Glutsch, Hermann Kneitz, Anja Gesierich, et al.
International Journal of Cancer|March 26, 2013
Vemurafenib reverses immunosuppression by myeloid derived suppressor cellsBastian Schilling, Antje Sucker, Klaus Griewank, et al.
Pageof 17